{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:25:17Z","timestamp":1787862317330,"version":"build-2784847793"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.acra.2026.07.065","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:50:43Z","timestamp":1787777443000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiparametric MRI-Based Interpretable Machine Learning Radiomics Model for Predicting Neoadjuvant Chemotherapy Sensitivity and Recurrence-Free Survival in Breast Cancer"],"prefix":"10.1016","author":[{"given":"Xinyi","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0014-9211","authenticated-orcid":false,"given":"Jidong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.acra.2026.07.065_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.acra.2026.07.065_bib2","unstructured":"World Health Organization. Breast cancer. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer. Published 2022. Accessed March 23, 2022."},{"issue":"8","key":"10.1016\/j.acra.2026.07.065_bib3","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/annonc\/mdz201","article-title":"The ESMO clinical practise guidelines for early breast cancer: diagnosis, treatment and follow-up: on the winding road to personalized medicine","volume":"30","author":"Loi","year":"2019","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.acra.2026.07.065_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10549-018-4990-9","article-title":"Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set","volume":"173","author":"Cain","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"10.1016\/j.acra.2026.07.065_bib5","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3390\/cancers13102298","article-title":"Early prediction of breast cancer recurrence for patients treated with neoadjuvant chemotherapy: A transfer learning approach on dce-mris","volume":"13","author":"Comes","year":"2021","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.acra.2026.07.065_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10278-018-0144-1","article-title":"Prior to initiation of chemotherapy,\u00a0can we predict breast tumor response? Deep learning convolutional neural networks approach using a breast MRI tumor dataset","volume":"32","author":"Ha","year":"2019","journal-title":"J Digit Imaging"},{"issue":"2","key":"10.1016\/j.acra.2026.07.065_bib7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1148\/radiol.2017170143","article-title":"Features from computerized texture analysis of breast cancers at pretreatment MR imaging are associated with response to neoadjuvant chemotherapy","volume":"286","author":"Chamming's","year":"2018","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.acra.2026.07.065_bib8","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1148\/radiol.2018172300","article-title":"MR imaging of rectal cancer: radiomics analysis to assess treatment response after neoadjuvant therapy","volume":"287","author":"Horvat","year":"2018","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.acra.2026.07.065_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00330-019-06347-w","article-title":"Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules","volume":"30","author":"Mokrane","year":"2020","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.acra.2026.07.065_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jmri.28273","article-title":"Four-dimensional machine learning radiomics for the pretreatment assessment of breast cancer pathologic complete response to neoadjuvant chemotherapy in dynamic contrast-enhanced MRI","volume":"57","author":"Caballo","year":"2023","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.acra.2026.07.065_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103042","article-title":"MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2\u00a0overexpressing breast cancer","volume":"61","author":"Bitencourt","year":"2020","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.acra.2026.07.065_bib12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10549-008-0025-2","article-title":"Prognostic imaging in neoadjuvant chemotherapy of locally-advanced breast cancer should be cost-effective","volume":"114","author":"Schegerin","year":"2009","journal-title":"Breast Cancer Res\u00a0Treatment"},{"issue":"3","key":"10.1016\/j.acra.2026.07.065_bib13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.6004\/jnccn.2018.0012","article-title":"Breast cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology","volume":"16","author":"Gradishar","year":"2018","journal-title":"J\u00a0Nat\u00a0Comprehensive Cancer Netw"},{"issue":"17","key":"10.1016\/j.acra.2026.07.065_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71221","article-title":"Interpretable machine learning for predicting neoadjuvant chemotherapy response in breast cancer using the baseline clinical and pathological characteristics","volume":"14","author":"Fang","year":"2025","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.acra.2026.07.065_bib15","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.celrep.2018.06.110","article-title":"Ki67 is a graded rather than a binary marker of proliferation versus quiescence","volume":"24","author":"Miller","year":"2018","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.acra.2026.07.065_bib16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13643-024-02520-5","article-title":"Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysis","volume":"13","author":"Bahrin","year":"2024","journal-title":"Syst Rev"},{"issue":"6","key":"10.1016\/j.acra.2026.07.065_bib17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1042\/EBC20200163","article-title":"Progesterone receptors in normal breast development andbreast cancer","volume":"65","author":"Giulianelli","year":"2021","journal-title":"Essays Biochem"},{"issue":"1","key":"10.1016\/j.acra.2026.07.065_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10549-017-4480-5","article-title":"Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer\u00a0patients: a pooled analysis of individual patient data from ten prospectively randomized controlled\u00a0neoadjuvant trials","volume":"167","author":"Van Mackelenbergh","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"10.1016\/j.acra.2026.07.065_bib19","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1001\/jamaoncol.2021.3690","article-title":"Assessment of residual\u00a0cancer burden and event-free survival in neoadjuvant treatment for\u00a0high-risk breast cancer: an analysis of data from the I-SPY2\u00a0randomized clinical trial","volume":"7","author":"Symmans","year":"2021","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.acra.2026.07.065_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10549-017-4480-5","article-title":"Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and\u00a0progesterone receptor-negative breast cancer patients: a pooled analysis of individual patient data from ten prospectively randomized controlled\u00a0neoadjuvant trials","volume":"167","author":"Van Mackelenbergh","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.acra.2026.07.065_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13244-023-01404-x","article-title":"Radiomics model to classify mammary masses using breast DCE-MRI compared to the BI-RADS classification performance","volume":"14","author":"Debbi","year":"2023","journal-title":"Insights Imaging"},{"issue":"10","key":"10.1016\/j.acra.2026.07.065_bib22","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1007\/s00261-021-03137-1","article-title":"A radiomics-based nomogram for preoperative T staging prediction of rectal cancer","volume":"46","author":"Lin","year":"2021","journal-title":"Abdom Radiol"},{"issue":"10","key":"10.1016\/j.acra.2026.07.065_bib23","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1007\/s00330-021-07910-0","article-title":"Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE","volume":"31","author":"Kong","year":"2021","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.acra.2026.07.065_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/RCT.0000000000000978","article-title":"Combining dynamic contrast-enhanced magnetic resonance imaging and apparent diffusion coefficient maps for a radiomics nomogram to predict pathological complete response to neoadjuvant chemotherapy in breast cancer patients","volume":"44","author":"Chen","year":"2020","journal-title":"J Comput Assist Tomogr"},{"issue":"1115","key":"10.1016\/j.acra.2026.07.065_bib25","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200287","article-title":"Radiomic signatures derived from multiparametric MRI for the pretreatment prediction of response to neoadjuvant chemotherapy in breast cancer","volume":"93","author":"Bian","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.acra.2026.07.065_bib26","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.2147\/CMAR.S304547","article-title":"Value of machine learning with multiphases CE-MRI radiomics for early prediction of pathological complete response to neoadjuvant therapy in HER2-positive invasive breast cancer","volume":"13","author":"Li","year":"2021","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.acra.2026.07.065_bib27","article-title":"Deep learning radiomic analysis of DCE-MRI combined with clinical characteristics predicts pathological complete response to neoadjuvant chemotherapy in breast cancer","volume":"12","author":"Li","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.acra.2026.07.065_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejca.2021.01.028","article-title":"Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer","volume":"147","author":"Jiang","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.acra.2026.07.065_bib29","article-title":"Treatment response prediction using ultrasound-based pre-, post-early, and delta radiomics in neoadjuvant chemotherapy in breast cancer","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.acra.2026.07.065_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1148\/radiol.2019182718","article-title":"Texture analysis with 3.0-T MRI for association of response to neoadjuvant chemotherapy in breast cancer","volume":"294","author":"Eun","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2026.07.065_bib31","first-page":"19","article-title":"Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using radiomics of pretreatment dynamic contrast-enhanced MRI","volume":"92","author":"Yoshida","year":"2022","journal-title":"Magn\u00a0Reson\u00a0Imaging"},{"issue":"12","key":"10.1016\/j.acra.2026.07.065_bib32","first-page":"3538","article-title":"Radiomics of multiparametric MRI for pretreatment prediction of pathologic complete response to neoadjuvant chemotherapy in breast cancer: a multicenter study","volume":"25","author":"Liu","year":"2019","journal-title":"Clin\u00a0Cancer Res"},{"key":"10.1016\/j.acra.2026.07.065_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174271","article-title":"Radiomics of MRI for the prediction of the pathological response to neoadjuvant chemotherapy in breast cancer patients: a single referral centre analysis","volume":"13","author":"Pesapane","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.acra.2026.07.065_bib34","first-page":"627","article-title":"Correlation between Shapley values of rooted phylogenetic trees under the beta-splitting model","volume":"80","author":"Fuchs","year":"2020","journal-title":"J\u00a0Mathem\u00a0Biol"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107663322600574X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107663322600574X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:07:30Z","timestamp":1787861250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107663322600574X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":34,"alternative-id":["S107663322600574X"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2026.07.065","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiparametric MRI-Based Interpretable Machine Learning Radiomics Model for Predicting Neoadjuvant Chemotherapy Sensitivity and Recurrence-Free Survival in Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2026.07.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}